BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16173081)

  • 1. Distinct localizations and repression activities of MM-1 isoforms toward c-Myc.
    Hagio Y; Kimura Y; Taira T; Fujioka Y; Iguchi-Ariga SM; Ariga H
    J Cell Biochem; 2006 Jan; 97(1):145-55. PubMed ID: 16173081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of the c-fms gene in fibroblast cells by c-Myc-MM-1-TIF1beta complex.
    Satou A; Hagio Y; Taira T; Iguchi-Ariga SM; Ariga H
    FEBS Lett; 2004 Aug; 572(1-3):211-5. PubMed ID: 15304350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants.
    Pineda-Lucena A; Ho CS; Mao DY; Sheng Y; Laister RC; Muhandiram R; Lu Y; Seet BT; Katz S; Szyperski T; Penn LZ; Arrowsmith CH
    J Mol Biol; 2005 Aug; 351(1):182-94. PubMed ID: 15992821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing in protein associated with Myc (Pam) influences its binding to c-Myc.
    Santos TM; Han S; Bowser M; Sazani K; Beauchamp RL; Murthy V; Bhide PG; Ramesh V
    J Neurosci Res; 2006 Feb; 83(2):222-32. PubMed ID: 16342205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter-binding and repression of PDGFRB by c-Myc are separable activities.
    Mao DY; Barsyte-Lovejoy D; Ho CS; Watson JD; Stojanova A; Penn LZ
    Nucleic Acids Res; 2004; 32(11):3462-8. PubMed ID: 15226411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of the Wnt signal by MM-1 through inhibiting expression of the wnt4 gene.
    Yoshida T; Kitaura H; Hagio Y; Sato T; Iguchi-Ariga SM; Ariga H
    Exp Cell Res; 2008 Apr; 314(6):1217-28. PubMed ID: 18281035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
    Zhu CY; Li CY; Li Y; Zhan YQ; Li YH; Xu CW; Xu WX; Sun HB; Yang XM
    Cell Death Differ; 2009 Mar; 16(3):395-405. PubMed ID: 19008924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human c-Myc isoforms differentially regulate cell growth and apoptosis in Drosophila melanogaster.
    Benassayag C; Montero L; ColombiƩ N; Gallant P; Cribbs D; Morello D
    Mol Cell Biol; 2005 Nov; 25(22):9897-909. PubMed ID: 16260605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transrepression pathway of c-Myc. Recruitment of a transcriptional corepressor complex to c-Myc by MM-1, a c-Myc-binding protein.
    Satou A; Taira T; Iguchi-Ariga SM; Ariga H
    J Biol Chem; 2001 Dec; 276(49):46562-7. PubMed ID: 11585818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming ability of Gag-Myc fusion proteins correlates with Gag-Myc protein stability and transcriptional repression.
    Law W; Linial ML
    Oncogene; 2001 Mar; 20(9):1118-27. PubMed ID: 11314049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
    Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
    Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AP4 encodes a c-MYC-inducible repressor of p21.
    Jung P; Menssen A; Mayr D; Hermeking H
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of Mxi1-SRalpha and Mxi1-SRbeta in Myc antagonism.
    Dugast-Darzacq C; Grange T; Schreiber-Agus NB
    FEBS J; 2007 Sep; 274(17):4643-53. PubMed ID: 17697116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAB-containing zinc finger gene ZNF268 encodes multiple alternatively spliced isoforms that contain transcription regulatory domains.
    Shao H; Zhu C; Zhao Z; Guo M; Qiu H; Liu H; Wang D; Xue L; Gao L; Sun C; Li W
    Int J Mol Med; 2006 Sep; 18(3):457-63. PubMed ID: 16865230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
    de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
    Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-myc: N-terminal recognition of myc binding proteins.
    Burton RA; Mattila S; Taparowsky EJ; Post CB
    Biochemistry; 2006 Aug; 45(32):9857-65. PubMed ID: 16893186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N; Hill AD; Young LS
    J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.